Brings Xevo TQ Absolute XR Mass Spectrometer's industry-leading tandem quadrupole MS sensitivity to clinical applications across women's health, cancer assessment, and toxicology ...
This trial will evaluate the Group’s proprietary coronary paclitaxel drug-coated balloon (DCB)...
The international research team found that resistant cancer cells can hijack a specific DNA repair defence mechanism to protect themselves from the effects of PARP inhibitors...
The i-SIGHT2 pivotal trial is evaluating a noninvasive office-based bioelectric therapy for intermediate to advanced dry age-related macular degeneration. ...
Disruptive innovation provides NHS Trusts faster access to continuous IV monitoring to reduce avoidable extravasation harm...
Six health systems and organizations awarded funding to improve patient access to cancer care through optimizing molecular testing pathways, biomarker-driven treatment selection, and precision oncology implementation in metastatic colorectal cancer...
The advancement of ADC 2.0 candidates AK146D1 and AK138D1 into Phase II trials marks a critical milestone for Akeso's "IO2.0 + ADC2.0" strategy...
The first-in-human study showed that wearable auricular neurostimulation enhanced platelet function without systemic effects or adverse events....
Findings from the multi-center Articulate Pro study show Paige Prostate improves diagnostic consistency, accelerates turnaround times, and reduces laboratory workloads...
The disease is projected to become the fifth leading cause of death by 2040 if diagnosis and treatment rates do not improve...
